Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Re-Positioning Protein-Kinase Inhibitors Against Schistosomiasis

1 Apr 2015

Abstract excerpt

For decades, Praziquantel (PZQ) is the drug of choice against one of the most afflicting helminthic diseases worldwide, schistosomiasis. With respect to the fear of upcoming PZQ resistance, efforts are needed to find new chemotherapeutic options. Protein kinases (PKs) are essential molecules in signaling processes and indispensable to life. Aberrant PK functions take distinctive roles in human diseases and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Helminth infection and control
Share to Parasites and Host Interactions
Share to Research on Leishmaniasis Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25996067
DOI: 10.4155/fmc.15.31

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Re-Positioning Protein-Kinase Inhibitors Against SchistosomiasisPMID 25996067Read ↗

Protein Kinases as Potential Targets for Novel Anti-Schistosomal StrategiesSemantic proximity Read ↗

Defining the Schistosoma haematobium kinome enables the prediction of essential kinases as anti-schistosome drug targetsSemantic proximity Read ↗

Protein tyrosine kinases as new potential targets against human schistosomiasisSemantic proximity Read ↗

Protein Kinases as Targets for Antiparasitic Chemotherapy DrugsSemantic proximity Read ↗

Antimalarial drug discovery: targeting protein kinasesSemantic proximity Read ↗

Imatinib Treatment Causes Substantial Transcriptional Changes in Adult Schistosoma mansoni In Vitro Exhibiting Pleiotropic EffectsSemantic proximity Read ↗

A genome-scale drug discovery pipeline uncovers therapeutic targets and a unique p97 allosteric binding site in Schistosoma mansoniSemantic proximity Read ↗

Parasite and host kinases as targets for antimalarialsSemantic proximity Read ↗

Proteins as Targets in Anti-Schistosomal Drug Discovery and Vaccine DevelopmentSemantic proximity Read ↗

A genome-scale drug discovery pipeline uncovers new therapeutic targets and a unique p97 allosteric binding site in <i>Schistosoma mansoni</i>Semantic proximity Read ↗

Drugging the Schistosome Zinc-Dependent HDACs: Current Progress and Future PerspectivesSemantic proximity Read ↗

Plasmodial Kinase Inhibitors: License to Cure?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.